Table 2.
Revenue sources |
Weifang, 2007 (pre-reform) |
Weifang, 2009 (post-reform) |
City Y, 2009 (comparison city) |
|||
---|---|---|---|---|---|---|
Public | Private | Public | Private | Public | Private | |
Subsidies for preventive services*1 |
Yes, according to the preventive services provided. |
No. |
Yes, decided by number of served residents and evaluation based on the contract. |
Yes, same as for public CHS. |
Yes, decided by number of served residents and evaluation based on the contract. |
Yes, same as for public CHS. |
Subsidies for staff training |
No. |
No. |
Yes, government provides some free training programs. |
Yes, same as for public CHS. |
Yes. |
No. |
Subsidies for personnel |
Yes, per capita budget and payment for retirees’ social insurance. |
No. |
Yes, same as before. |
No. |
Yes. |
No. |
Subsidies for rental or purchase of land and clinic space |
Yes, but amount differs according to CHS scale and scope. |
No. |
Yes, same as before. |
No. |
Yes. |
No. |
Subsidies for equipment |
Yes. |
No. |
Yes, one time 60,000RMB investment. |
Yes, one time 60,000RMB investment. Refund to government if CHS withdraws from the CHS network. |
Yes. |
No. |
Subsidies for EML drugs*2 |
N/A (EML drug policy not yet launched.) |
N/A (EML drug policy not yet launched.) |
Yes, sell at acquisition price to patient; government pays the CHS the original 15% mark up for dispensing EML drugs. |
Yes, same as for public CHS |
N/A (EML drug policy not yet launched.) |
N/A (EML drug policy not yet launched.) |
Fee for service from out-of-pocket payments |
Patients charged according to government-set fixed or “guide” prices. |
CHS has autonomy in setting prices. |
Same as before. |
CHS retains price-setting autonomy, but cannot exceed government “guide” prices. |
Patients charged according to government-set fixed or “guide” prices. |
CHS has autonomy in setting prices. |
Fee for service paid by urban employee insurance *4 |
Covered, but no difference from hospital outpatient care in terms of patient co-payment. |
Not covered by the social insurance network. |
Covered, and at a more generous rate than hospitals. Patient co-payments are lower than for hospital outpatient visits. |
Yes, same as for public CHS. |
Covered, but no difference from hospital outpatient care in terms of patient co-payment. |
Not covered by the social insurance network. |
Fee for service paid by urban residents insurance *4 | N/A (Urban residents insurance not yet launched.) | N/A (Urban residents insurance not yet launched.) | Covered, and at a more generous rate than hospitals. Patient co-payments are lower than for hospital outpatient visits. | Yes, same as for public CHS | Covered, but no difference from hospital outpatient care in terms of patient co-payment. | Not covered by the social insurance network. |
*1. The subsidies are decided by (a) the evaluation score as described in Table 1; and (b) the number of served residents. In 2008 and 2009, the per capita budget for public health services was 10RMB. CHS with a score above 80 got 100% of the budget; CHS scoring between 70 and 80 got 90% of the budget; CHS scoring between 60 and 70 got 80% of the budget; CHS scoring between 50 and 60 got 60% of the budget; and CHS scoring under 50 got no subsidies.
*2. The 70 drugs listed on the Essential Medicine List must be sold to patients at the acquisition price; if prescriptions from the EML represent more than 30% of all prescriptions, the CHS receives a subsidy from the government equivalent to 15% of the drug price.
*3. The chronic diseases for which the CHS can be reimbursed by health insurance for associated outpatient expenses include stroke, diabetes, chronic viral hepatitis, and autoimmune hepatitis.
*4. For the service items covered by insurance, CHS are reimbursed by insurers and patient copayments.